
| Salt Composition: | Bevacizumab (25mg/ml) |
| Manufacturer: | Cipla Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Syndyma 400mg/16ml Injection is an anticancer medication used to treat various types of cancer, including colon and rectum, non-small cell lung, kidney, brain, ovarian, and cervical cancer. Syndyma 400mg/16ml Injection is an effective medicine and first-line option when used together with other cancer medicines. It is given as an infusion, and your doctor will decide your dose and duration. You may experience side effects such as rectal bleeding, taste change, and headache. Inform your doctor if you notice any unusual bleeding or bleeding that doesn't stop easily. You may be advised to check blood pressure and levels of protein in urine while taking this medication.
Syndyma 400mg/16ml Injection is a anti-angiogenic medication that works by blocking a protein called vascular endothelial growth factor (VEGF), which stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Alcohol
It is not known whether it is safe to consume alcohol with Syndyma 400mg/16ml Injection. Please consult your doctor.
Breastfeed
Syndyma 400mg/16ml Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Syndyma 400mg/16ml Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.